Last week, I introduced "Mrs. Ozurdex," an elderly female who has a central retinal vein occlusion in her right eye. Several weeks ago, I implanted a sustained release steroid delivery system, called Ozurdex® (Allergan). Ozurdex is indicated, and FDA approved, for the treatment of CRVO. If you recall, another patient, "Mr. Ozurdex" had a branch retinal vein occlusion. He, too, received … [Read more...]
Iluvien® For Diabetic Macular Edema Has Eyes on FDA
December 28, 2009 By Leave a Comment
™Alimera Sciences' "Iluvien®" moves closer to FDA approval for the treatment of diabetic macular edema. Iluvien is an extended release drug delivery system designed for direct intravitreal injection to the eye. Iluvien will release a steroid, fluocinolone acetonide, for up to 36 months to treat retinal swelling. The company has announced pivotal results in the ongoing FAME (Fluocinolone … [Read more...]
Retinal Vein Occlusions – New Hope on the Horizon
July 8, 2009 By Leave a Comment
There are two types of retinal vein occlusions (RVO), branch retinal vein occlusions (BRVO) and central retinal vein occlusion (CRVO). In both of these scenarios, the central vein that drains blood from the retina becomes occluded partially (as in the case of BRVO) or completely (as in the case of CRVO). The mainstay of treatment for either has been treatment with an argon laser. The idea is … [Read more...]
